NCT07393568|Not Yet Recruiting
Loading search results
Sponsor study identifier
observational
94
0 countries
N/A
Study Start
February 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Generative artificial intelligence (AI), including large language models such as ChatGPT, Gemini, and Copilot, is increasingly used by patients to obtain medical information and prepare for clinical encounters. Although these tools often provide guideline-consistent information, their responses may be incomplete, inaccurate, or lack personalization, potentially influencing patient expectations and clinical interactions. The impact of patient AI use on satisfaction, adherence, and physician-patient communication remains poorly understood. This prospective comparative study will evaluate the effects of patient AI use prior to gynecologic consultations for endometriosis. Women attending a specialized endometriosis clinic will be categorized as AI users or non-users based on their preparation for the visit. Patient-reported outcomes, including satisfaction, expectations, adherence to physician recommendations, and pain during physical examination, will be assessed using validated questionnaires and visual analogue scales. Physicians, blinded to AI use, will independently assess patient engagement, trust, and compliance. Visit duration will also be recorded. The primary objective is to determine whether AI use affects patient satisfaction and adherence to treatment recommendations. Secondary objectives include evaluating physician-perceived interaction quality and concordance between AI-generated guidance and physician recommendations. Findings from this study will provide critical evidence on how AI influences patient behavior and clinical care in endometriosis, informing best practices for integrating AI-informed patients into routine clinical encounters.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 17, 2025
Actual (reported)February 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
February 6, 2026
Actual (reported)January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Patient Satisfaction and Treatment Plan Adherence After Consultation
Overall patient satisfaction will be measured immediately after the endometriosis consultation using a structured post-visit questionnaire and reported as a score on a 0-5 scale, where 0 indicates not satisfied at all and 5 indicates very satisfied. Intention to adhere to the physician's treatment plan will be measured immediately after the consultation as a binary outcome (yes/no) based on the patient's response to the post-visit questionnaire item asking whether she intends to follow the doctor's treatment recommendations.
Immediately after the consultation (same day)
Physician-Perceived Interaction Quality and Consultation Characteristics
During and immediately after the consultation (same day)
using Chat gpt before outpatient clinic visit
This study involves a behavioral, non-randomized observational intervention based on patients' self-directed use of generative artificial intelligence (AI) tools prior to their clinical visit. The intervention group consists of patients who report using AI-based large language models (e.g., ChatGPT or similar tools) to prepare for their endometriosis-related consultation. AI use may include seeking information about symptoms, diagnosis, treatment options, prognosis, or formulating questions for the physician. No specific AI platform, prompts, or duration of use is mandated, and AI engagement occurs independently and outside the clinical setting. The control group includes patients who report no use of AI tools in preparation for the visit. No AI tools are introduced, recommended, or used during the clinical encounter by study personnel. Physicians are blinded to patient AI use status and conduct consultations according to standard clinical practice. Aside from questionnaire administ
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The study population will consist of adult women (aged ≥18 years) attending a specialized gynecology outpatient clinic for evaluation or management of endometriosis-related complaints. Eligible participants must be able to provide informed consent and complete study questionnaires independently. Participants will include both new and returning patients with suspected or confirmed endometriosis. Individuals with cognitive impairment or psychiatric conditions that significantly interfere with communication or the ability to provide informed consent will be excluded. Following enrollment, participants will be categorized based on self-reported use of generative artificial intelligence (AI) tools to prepare for their clinical visit. Demographic and baseline clinical characteristics-including age, ethnicity, body mass index, smoking status, medical comorbidities, reproductive history, and prior surgical history-will be collected to characterize the study population and allow for compariso
First Submitted
December 17, 2025
First Posted
February 6, 2026
Study Start
February 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
January 1, 2027
EstimatedCharacterization of Immune Cells and Their Secreted Cytokines in Endometriosis Patients
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 6, 2026
Record last verified: 2026-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: